Metabolic dysfunction‐associated steatotic liver disease, cardiometabolic risk factors, and cardiac manifestations in psoriasis: A cross‐sectional study of 255 patients
Journal of Internal Medicine · 2026-02 · 299 (2) · 283-299
DOI: 10.1111/joim.70053 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Internal Medicine, online erschienen am 30.11.2025. Verfasst von Maria Dons und 12 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Non-Invasive Imaging Research Laboratory, Department of Cardiology, Copenhagen University Hospital-Herlev & Gentofte Hospital, Univers…. Hauptthemen laut MEDLINE: Psoriasis, Cardiometabolic Risk Factors, Fatty Liver. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Karen Elise Jensen's Foundation, Lundbeck Foundation, LEO Foundation.
Abstract (Originalsprache)
Background
Individuals with psoriasis have a high prevalence of metabolic dysfunction–associated steatotic liver disease (MASLD), yet the association between MASLD as a cardiometabolic risk factor and cardiac manifestations in this population remains unclear.
Objectives
We aimed to evaluate associations between MASLD, cardiometabolic risk factors, and cardiac structure and function in adults with psoriasis.
Methods
We performed a cross‐sectional analysis of 255 adults with psoriasis prospectively enrolled. Participants underwent transthoracic echocardiography and transient elastography. MASLD was defined by hepatic steatosis with a controlled attenuation parameter of ≥250 dB/m and the presence of ≥1 cardiometabolic risk factor(s), excluding other liver disease causes. Cardiac structure and function were compared between individuals with psoriasis and MASLD and those without MASLD. Associations between MASLD and myocardial dysfunction were assessed in uni‐ and multivariable regression models.
Results
MASLD was present in 92 participants (36.1%), of whom 5 (5.4%) had evidence of increased liver stiffness. Those with MASLD exhibited higher blood pressure, body mass index (BMI), and more adverse cardiometabolic profiles. MASLD was associated with cardiac structural changes and worse diastolic and systolic function. After adjusting for age, sex, and BMI, most associations were attenuated. In fully adjusted models, higher BMI and diabetes, but not MASLD, were independently associated with myocardial dysfunction.
Conclusions
In adults with psoriasis, the association between MASLD and cardiac structural and functional changes was attenuated after adjusting for BMI and cardiometabolic risk factors, underscoring the importance of cardiometabolic risk factor control, in particular of obesity and diabetes, in psoriasis with concomitant MASLD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cardiovascular Non-Invasive Imaging Research Laboratory, Department of Cardiology, Copenhagen University Hospital-Herlev & Gentofte Hospital, University of Copenhagen, Copenhagen, Denmark.
- Center for Translational Cardiology and Pragmatic Randomized Trials, Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
- Department of Dermatology and Allergy, Copenhagen University Hospital-Herlev & Gentofte, Copenhagen, Denmark.
- Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
- Leo Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
- Division of Cardiovascular Imaging, Department of Cardiovascular Medicine, Heart and Vascular Center, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
ORCID-Profile: Maria Dons, Filip Soeskov Davidovski, Lise Lotte Gluud, Lone Skov
Förderung
- Karen Elise Jensen's Foundation
- Lundbeck Foundation
- LEO Foundation
- Copenhagen University Hospital - Herlev & Gentofte
- LEO Fondet
Zitieren
APA
Dons, M., Näslund-Koch, C., Sengeløv, M., Bøgh-Sørensen, S., Skaarup, K. G., Løvendorf, M. B., Davidovski, F. S., Jensen, A. M. R., Weber, B. N., Gluud, L. L., Zachariae, C., Skov, L., & Biering-Sørensen, T. (2026). Metabolic dysfunction‐associated steatotic liver disease, cardiometabolic risk factors, and cardiac manifestations in psoriasis: A cross‐sectional study of 255 patients. Journal of Internal Medicine, 299(2), 283-299. https://doi.org/10.1111/joim.70053
Vancouver
Dons M, Näslund-Koch C, Sengeløv M, Bøgh-Sørensen S, Skaarup KG, Løvendorf MB, et al. Metabolic dysfunction‐associated steatotic liver disease, cardiometabolic risk factors, and cardiac manifestations in psoriasis: A cross‐sectional study of 255 patients. Journal of Internal Medicine. 2026;299(2):283-299. doi:10.1111/joim.70053
BibTeX
@article{Dons2026,
author = {Dons, Maria and Näslund-Koch, Charlotte and Sengeløv, Morten and Bøgh-Sørensen, Sofie and Skaarup, Kristoffer Grundtvig and Løvendorf, Marianne Bengtson and Davidovski, Filip Soeskov and Jensen, Anne Marie Reimer and Weber, Brittany N and Gluud, Lise Lotte and Zachariae, Claus and Skov, Lone and Biering-Sørensen, Tor},
title = {Metabolic dysfunction‐associated steatotic liver disease, cardiometabolic risk factors, and cardiac manifestations in psoriasis: A cross‐sectional study of 255 patients},
journal = {Journal of Internal Medicine},
year = {2026},
volume = {299},
number = {2},
pages = {283--299},
doi = {10.1111/joim.70053}
}
EUVIMED